Sleep Disorders Trial, Recruiting NCT06594627 Sponsor: Indiana University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06594627
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people who snore or have sleep apnea (OSA):

  • People aged 50 years or older.
  • People who snore and/or have sleep apnea (OSA) in a way that affects their own sleep quality or their sleep partner's sleep quality.
  • People who are currently using a snoring or sleep apnea treatment, or those who are not using any treatment — participation does not require stopping any current treatments.
  • People who own a smartphone that runs Apple iOS 15 or higher, or Android 10 or higher.
  • People with or without a sleep partner.
  • People who do not have a pacemaker.
  • People who do not have electrodes implanted in the brain.
  • People who do not have neck pain related to spine problems in the neck area, including disc, muscle, or nerve issues.

For sleep partners:

  • People aged 18 years or older.
  • People who share a sleeping space with a partner who snores or has sleep apnea, more than four nights per week.
  • People whose snoring/sleep apnea partner has also agreed to take part in the study.

Who may not be able to join:

  • Anyone who is not able to give their own consent or complete the study activities independently, as assessed by the trial investigator.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chang Dae Lee, PhD, Indiana University

Phone: 317-274-5365

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 November 2024
Est. completion
11 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Participant Subjective Sleep Quality (PSQI); Change in Participant Subjective Sleep Quality (novel sleep quality questionnaire); Change in Participant total sleep time; Change in Participant sleep periods; Change in Participant REM sleep time; Change in Participant Snoring time; Change in Participant Depressive symptoms; Change in Participant blood oxygen level; Change in Participant physical activity level; Change in Participant's subjective cognitive function; Change in Participant's objective cognitive function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov